| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Neil Harris Cohen is Director at CMMB. Neil Harris Cohen's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $43K at current prices.
Historically, Neil Harris Cohen's trades have earned a below-average insider score of 29/100 across 5 rated trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -39.9%.
Net of sales, the CMMB filings show accumulation of 7,696 shares.
Neil Harris Cohen has 10 Form 4 filings on record from April 2020 to August 2026, all as Director at Chemomab Therapeutics (CMMB), 2020–2026.
The 33 reported transactions were 23 option or other derivative awards, 7 open-market purchases and 3 open-market sales.
Counted by filing, the open-market trades come to 4 purchases worth about $147K and 2 sales worth about $11K.
The largest open-market purchase was 2,409 shares of CMMB at an average $41.51 on March 16, 2021, about $100K. Twelve months later CMMB was down 94%.
The largest open-market sale was 2,304 shares of CMMB at an average $2.83 on August 28, 2026, about $7K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | CMMB Chemomab Therapeutics Ltd. | Director | Sell | 2,304 | $2.83 | $6,516.40 | -6.5% | - | - | |
| Nov 16, 2022 | CMMB Chemomab Therapeutics Ltd. | Director | Sell | 2,409 | $2.00 | $4,818.00 | -19.4% | -9.2% | -71.1% | |
| May 18, 2022 | CMMB Chemomab Therapeutics Ltd. | Director | Buy | 2,000 | $3.19 | $6,380.00 | +19.2% | +21.9% | -39.9% | |
| Mar 14, 2022 | CMMB Chemomab Therapeutics Ltd. | Director | Buy | 6,000 | $4.35 | $26,120.00 | +136.1% | -15.4% | -62.5% | |
| Dec 6, 2021 | CMMB Chemomab Therapeutics Ltd. | Director | Buy | 2,000 | $7.43 | $14,860.00 | +83.0% | -52.5% | -73.6% | |
| Mar 16, 2021 | CMMB Chemomab Therapeutics Ltd. | Director | Buy | 2,409 | $41.51 | $99,997.59 | New | -70.7% | -94.4% |